435 related articles for article (PubMed ID: 19608888)
1. Insulin resistance. Prosperity's plague.
Taubes G
Science; 2009 Jul; 325(5938):256-60. PubMed ID: 19608888
[No Abstract] [Full Text] [Related]
2. How obesity causes diabetes: not a tall tale.
Lazar MA
Science; 2005 Jan; 307(5708):373-5. PubMed ID: 15662001
[TBL] [Abstract][Full Text] [Related]
3. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
[TBL] [Abstract][Full Text] [Related]
4. Monocyte chemotactic protein-1 and its role in insulin resistance.
Sell H; Eckel J
Curr Opin Lipidol; 2007 Jun; 18(3):258-62. PubMed ID: 17495598
[TBL] [Abstract][Full Text] [Related]
5. Diabetes, obesity, and the brain.
Schwartz MW; Porte D
Science; 2005 Jan; 307(5708):375-9. PubMed ID: 15662002
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of obesity-associated insulin resistance: many choices on the menu.
Qatanani M; Lazar MA
Genes Dev; 2007 Jun; 21(12):1443-55. PubMed ID: 17575046
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, inflammation, and non-alcoholic fatty liver disease.
Tilg H; Moschen AR
Trends Endocrinol Metab; 2008 Dec; 19(10):371-9. PubMed ID: 18929493
[TBL] [Abstract][Full Text] [Related]
8. Diabetes, lipids, and adipocyte secretagogues.
Faraj M; Lu HL; Cianflone K
Biochem Cell Biol; 2004 Feb; 82(1):170-90. PubMed ID: 15052336
[TBL] [Abstract][Full Text] [Related]
9. Obesity, inflammation, and insulin resistance--a mini-review.
Zeyda M; Stulnig TM
Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
[TBL] [Abstract][Full Text] [Related]
10. Obesity, inflammation, and insulin resistance.
Shoelson SE; Herrero L; Naaz A
Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
[TBL] [Abstract][Full Text] [Related]
11. [Insulin signaling and insulin resistance].
Ferré P
Therapie; 2007; 62(4):277-84. PubMed ID: 17983553
[TBL] [Abstract][Full Text] [Related]
12. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease.
Parekh S; Anania FA
Gastroenterology; 2007 May; 132(6):2191-207. PubMed ID: 17498512
[TBL] [Abstract][Full Text] [Related]
13. Ceramides in insulin resistance and lipotoxicity.
Summers SA
Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
[TBL] [Abstract][Full Text] [Related]
14. Obesity with insulin resistance: experimental insights.
Clark MG; Rattigan S; Clark DG
Lancet; 1983 Nov; 2(8361):1236-40. PubMed ID: 6139579
[No Abstract] [Full Text] [Related]
15. [Relationship between obesity, inflammation and insulin resistance: new concepts].
Fève B; Bastard JP; Vidal H
C R Biol; 2006 Aug; 329(8):587-97; discussion 653-5. PubMed ID: 16860277
[TBL] [Abstract][Full Text] [Related]
16. Adipose tissue dysfunction in obesity.
Blüher M
Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
[TBL] [Abstract][Full Text] [Related]
17. The adipocyte IKK/NFkappaB pathway: a therapeutic target for insulin resistance.
Ruan H; Pownall HJ
Curr Opin Investig Drugs; 2009 Apr; 10(4):346-52. PubMed ID: 19337955
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria, body fat and type 2 diabetes: what is the connection?
Maasen JA
Minerva Med; 2008 Jun; 99(3):241-51. PubMed ID: 18497722
[TBL] [Abstract][Full Text] [Related]
19. Medicine. Visfatin: a new adipokine.
Hug C; Lodish HF
Science; 2005 Jan; 307(5708):366-7. PubMed ID: 15604359
[No Abstract] [Full Text] [Related]
20. Insulin resistance and steatosis in humans.
Capeau J
Diabetes Metab; 2008 Dec; 34(6 Pt 2):649-57. PubMed ID: 19195626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
